| Market revenue in 2023 | USD 1.6 million |
| Market revenue in 2030 | USD 2.0 million |
| Growth rate | 3.5% (CAGR from 2024 to 2030) |
| Largest segment | Outbred |
| Fastest growing segment | Knock Out |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Knock Out, Outbred, Inbred, Hybrid, Immunodeficient, Conditioned Rats |
| Key market players worldwide | Charles River Laboratories International Inc, Inotiv Inc, Labcorp Holdings Inc, Avista Corp, Joinn Laboratories (China) Co Ltd ADR, Janvier Labs, Transviragen, Cyagen Biosciences, genOway |
Publish Date: Nov 24, 2025
Last Updated: Aug 26, 2026
No credit card required*
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Charles River Laboratories International Inc | View profile | 21,400 | 251 Ballardvale Street, Wilmington, MA, United States, 01887 | www.criver.com |
| Labcorp Holdings Inc | View profile | 67,000 | 358 South Main Street, Burlington, NC, United States, 27215 | www.labcorp.com |
| Inotiv Inc | View profile | 2,055 | 2701 Kent Avenue, West Lafayette, IN, United States, 47906 | www.inotivco.com |
| Avista Corp | View profile | 1,858 | 1411 East Mission Avenue, Spokane, WA, United States, 99202-2600 | www.avistacorp.com |
| Joinn Laboratories (China) Co Ltd ADR | View profile | 2,510 | A5 Rongjing East Street, Beijing Economic-Technological Development Area, Beijing, China, People's Republic of, 100176 | www.joinnlabs.com |
| Janvier Labs | View profile | 251-500 | Le Genest, Pays de la Loire, France, Europe | janvier-labs.com |
| Transviragen | View profile | 1-10 | Charlotte, North Carolina, United States, North America | www.transviragen.com/ |
| Cyagen Biosciences | View profile | 501-1000 | Santa Clara, California, United States, North America | www.cyagen.com |
| genOway | View profile | 101-250 | Lyon, Rhone-Alpes, France, Europe | www.genoway.com |
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Rat Model Market Outlook will help companies and investors design strategic landscapes.
Outbred was the largest segment with a revenue share of 31.25% in 2023.
Horizon Databook has segmented the Kuwait rat model market based on knock out, outbred, inbred, hybrid, immunodeficient, conditioned rats covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the Kuwait Rat Model Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Kuwait Rat Model Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.